Multiple epidemiological studies confirm the robust and dose-dependent connection between raised Lp(a) levels and an increased risk of developing cardiovascular events, such as myocardial infarction and stroke, emphasizing the importance of Lp(a) screening as a vital part of overall heart health check-ups [10]. This evidence concerns the gene LPA and stroke disorder.